TAIPEI, 14. November 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) gab am 12. November den Abschluss eines zweiten globalen Exklusivlizenzvertrags mit dem internationalen Marktführer für Biosimilars, der Sandoz AG (SIX:SDZ/OTCQX:SDZNY), für die Vermarktung seines eigenständig...
Hence then, the article about eirgenix unterzeichnete die kommerzielle lizenzvereinbarung fur sein zweites her2 biosimilar eg1206a was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( EirGenix unterzeichnete die kommerzielle Lizenzvereinbarung für sein zweites HER2-Biosimilar EG1206A )
Also on site :
- What to Know About Allegations of Excessive Drinking by FBI Director Kash Patel
- Gunman opens fire and seizes supermarket in Kiev (VIDEOS)
- The Critically Acclaimed 2012 Best-Seller Named the 'Best Novel of the Century': 'Every Word is Finely Tuned'